Jacobs Levy Equity Management Inc. Makes New $1.71 Million Investment in Amdocs Limited $DOX

Key Points

• Jacobs Levy Equity Management Inc. has made a new investment in Amdocs Limited, purchasing 18,632 shares valued at approximately $1.7 million, according to its recent SEC filing.
• Amdocs has received a consensus rating of "Buy" from four equities research analysts, with a target price of $105.33.
• The company announced a quarterly dividend of $0.527, representing an annual yield of 2.5%, which will be paid on October 31st.

Jacobs Levy Equity Management Inc. acquired a new stake in Amdocs Limited (NASDAQ:DOX - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 18,632 shares of the technology company's stock, valued at approximately $1,705,000.

A number of other hedge funds also recently made changes to their positions in DOX. Alyeska Investment Group L.P. lifted its position in shares of Amdocs by 38.6% in the first quarter. Alyeska Investment Group L.P. now owns 2,329,767 shares of the technology company's stock valued at $213,174,000 after buying an additional 648,693 shares during the last quarter. American Century Companies Inc. lifted its position in shares of Amdocs by 23.5% in the first quarter. American Century Companies Inc. now owns 2,242,829 shares of the technology company's stock valued at $205,219,000 after buying an additional 426,911 shares during the last quarter. Nuveen LLC acquired a new stake in shares of Amdocs in the first quarter valued at approximately $36,921,000. LSV Asset Management lifted its position in shares of Amdocs by 11.1% in the first quarter. LSV Asset Management now owns 3,180,501 shares of the technology company's stock valued at $291,016,000 after buying an additional 317,412 shares during the last quarter. Finally, AQR Capital Management LLC lifted its position in shares of Amdocs by 43.0% in the first quarter. AQR Capital Management LLC now owns 955,158 shares of the technology company's stock valued at $86,719,000 after buying an additional 287,243 shares during the last quarter. 92.02% of the stock is owned by institutional investors and hedge funds.

Amdocs Price Performance

Shares of DOX stock traded down $0.33 during trading on Friday, hitting $85.00. The company had a trading volume of 555,419 shares, compared to its average volume of 810,267. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.22 and a current ratio of 1.22. The firm has a market capitalization of $9.60 billion, a P/E ratio of 17.24, a price-to-earnings-growth ratio of 1.56 and a beta of 0.54. The stock's 50-day moving average price is $87.18 and its 200 day moving average price is $88.54. Amdocs Limited has a one year low of $78.61 and a one year high of $95.41.

Amdocs (NASDAQ:DOX - Get Free Report) last issued its quarterly earnings results on Wednesday, August 6th. The technology company reported $1.72 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.01. The business had revenue of $1.14 billion during the quarter, compared to analysts' expectations of $1.13 billion. Amdocs had a return on equity of 19.66% and a net margin of 11.94%.The firm's revenue for the quarter was down 8.4% compared to the same quarter last year. During the same period in the previous year, the company posted $1.62 earnings per share. Equities analysts expect that Amdocs Limited will post 6.21 EPS for the current fiscal year.

Amdocs Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Tuesday, September 30th will be paid a $0.527 dividend. This represents a $2.11 annualized dividend and a dividend yield of 2.5%. The ex-dividend date is Tuesday, September 30th. Amdocs's payout ratio is 42.80%.

Analyst Ratings Changes

A number of analysts have recently issued reports on the company. Wolfe Research assumed coverage on Amdocs in a research report on Tuesday, July 8th. They issued an "outperform" rating for the company. Wall Street Zen raised Amdocs from a "hold" rating to a "buy" rating in a research report on Sunday, August 10th. Four investment analysts have rated the stock with a Buy rating, According to MarketBeat, the stock has a consensus rating of "Buy" and an average price target of $105.33.

Amdocs Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.